Posted in | News

BullMarket.com Provides New Coverage on Engineering & Construction Stocks

BullMarket.com, an online investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with updated coverage on Engineering & Construction Stocks, including Foster Wheeler (Nasdaq: FWLT), Fluor (NYSE: FLR), Shaw Group (NYSE: SHAW), Jacobs Engineering (NYSE: JEC), AECOM (NYSE: ACM), and Great Lakes Dredge & Docks (Nasdaq: GLDD).

All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008 and was up over 33% year to date at the end of September.

In its daily report, BullMarket.com wrote: "Foster Wheeler rightly considers itself to be a 'pure play' on building the world's energy infrastructure. It operates in two segments: Global Engineering & Construction and Global Power. The E&C segment builds refineries, delayed coking facilities, petrochemical plants, natural gas liquefaction (LNG) plants, and other related projects. The Global Power is focused on building solid-fuel steam generators, along with the auxiliary equipment, maintenance and services that accompany them. Foster Wheeler is the world leader in the building of coal-fired burners (CFBs), controlling 75% of the market."

BullMarket.com looked at the following topics, among others:

  • Which E&C firm looks most poised to benefit from government stimulus money?
  • What has helped Fluor perform well operationally despite the global downturn?
  • How has Shaw differentiated itself from other E&C companies?
  • What strategy is Jacobs using to expand its footprint?

Source: https://www.bullmarket.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.